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Abstract
The underlying mechanisms by which Newcastle disease virus (NDV) kills cancer cells are still unclear. Recent
discoveries have shown that many viruses contain Bcl-2 homology-like domains which enabled their interaction
with Bcl-2 family members, and thereby accounting for their virulence and pathogenicity. Alignment of the protein
sequences of Malaysian strain of NDV, known as AF2240, with those from members of the human Bcl-2 family
showed many similar regions; most notably we found that its matrix (AF2240-M) protein, large (AF2240-L) protein
and fusion (AF2240-F) protein all contain BH3-like regions. In addition, there are BH1-like domains in these proteins,
where AF2240-F and Mcl-1 share 55% identity within this region. To further investigate our hypothesis that the
presence of the BH3-like domains in these proteins may convey cytotoxicity, AF2240-M and AF2240-F genes were
cloned into pFLAG and pEGFP.N2 vectors and transfected into HeLa cells. The expression of these constructs
promoted cell death. As shown by flow cytometry, AF2240-M protein with deleted BH3-like region showed five-
fold decrease in apoptosis. Moreover, the construct containing the N-terminal of AF2240-M showed nearly the
same cell death rate as to that of the full-length protein, strongly suggesting that the BH3-like domain within this
protein participates in promoting cell death. Moreover, AF2240-M transfection promoted Bax redistribution to
mitochondria. Therefore, to determine whether there is any direct interaction between NDV viral proteins with
some members of the Bcl-2 family, various constructs were co-transfected into HeLa cells. Co-immunoprecipitation
trials showed that the AF2240-M indeed directly interacted with Bax protein via its BH3-domain, as the mutant
proteins failed to interact with Bax. AF2240-F failed to interact with any of the tested proteins, although Bcl-XL
slowed down the rate of cell death caused by this construct by nearly five-fold. In a parallel experiment, the level
of expression of endogenous Bax and Bcl-2 after infection of HeLa cells with NDV was assessed by qRT-PCR, but no
statistically significant change was observed. Consequently, the Bax/Bcl-2 ratio at the mRNA level did not alter.
Overall, our study has shed additional light into the mechanisms by which NDV induces apoptosis.
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Introduction
Newcastle disease virus (NDV), an avian paramyxovirus,
affects most species of birds and is considered one of
the most devastating viruses that can cause great eco-
nomic damage to the poultry industry [1]. Its many
strains have been mainly categorised by its pathotype
and clinical effects rather than by its structure. Strain
AF2240 is a viscerotropic velogenic strain of NDV that
causes a high mortality rate and was isolated during an
outbreak in the country in the 1960s. It is now used as
the challenge virus in vaccine trials in Malaysia [2].
NDV belongs to the genus Avulavirus from the family
of Paramyxoviridae [3]. It has a non-segmented single-
stranded negative-sense RNA genome of nearly 15 kb
[4-6]. The virion is enveloped with a lipid bilayer mem-
brane derived from the host cell membrane [7]. This
structure consists of 6 proteins. HN and F fusion glyco-
proteins are embedded in the lipid membrane. The
matrix (M) protein is associated with the inner surface
of the membrane. Inside the virion, three proteins,
nucleocapsid (NP), phosphoprotein (P), and large (L)
protein, constitute the viral transcriptase complex. The
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binding domains have yet to be defined completely [7].
Upon entry into the host cell, NDV genome is subjected
to two separate mechanisms of transcription and repli-
cation that result in the production of more viruses.
The F glycoprotein mediates virus fusion with the host
cellular membrane. Its gene has 1791 bp with an open
reading frame of 1662 bp and it codes for F0 precursor
with 553 amino acids. The precursor is then cleaved at
residues 116-117 to generate F1 and F2 disulphide-
linked polypeptides [8,9]. The transmembrane domain
of F is located at the C-terminal region of F1. Three
hapted repeat sites have been reported that are strain
specific [10] and also six glycosylation sites have been
previously identified [11].
The M gene of strain AF2240 has 1223 bp with an
ORF of 1093 bp. Its translated product contains 364
amino acids for all reported strains and has a molecular
weight of approximately 40 kDa [11]. It is relatively
hydrophobic and non-glycosylated with many basic resi-
dues. It has been reported that M is associated with the
N-terminal segment of HN protein located in its inner
surface [12]. It is also believed that it interacts with the
NP protein, but the exact binding domains are yet to be
determined [7]. The nucleocapsid itself is a herring-
bone-like structure comprising thousands of NP subu-
nits that are associated tightly with several copies of P
and L proteins.
NDV appears to selectively kill cancer cells while spar-
ing normal human cells [13]. It is believed that NDV
kills avian cells and human cancer cells by apoptosis
[14-16]. On the other hand, cell death through apoptosis
is initiated via either intrinsic or extrinsic pathway [17].
The Bcl-2 family of proteins plays an important role in
the regulation of mitochondrial checkpoints that are
involved in both intrinsic and extrinsic apoptotic signal-
ing pathways [18]. These proteins display both pro- and
anti-apoptotic functions [19] and have one or more of
the conserved domains known as the Bcl-2 homology
(BH) domains 1 to 4. These family members can inter-
act with each other or other proteins via these con-
served domains.
Numerous publications have demonstrated the anti-
or pro-apoptotic effects of viruses and their respective
viral proteins in eukaryotic cells [20], but it is only
recently that researchers have begun to investigate the
sequence similarity between viral proteins and cellular
apoptotic proteins. Since the late 20th century, it was
shown that some viruses contain protein homologs to
Bcl-2 family members and that many of these domains
enable these proteins to interact with Bcl-2 family mem-
bers [21-29]. These studies provide an initial clue on the
underlying mechanisms behind the apoptosis regulating
effect of these viruses.
Here, we report for the first time that NDV viral pro-
teins contain BH domain-like regions, and that AF2240-
M and AF2240-F display pro-apoptotic effect in HeLa
cells. Previously, it was shown that strain AF2240 has a
different HN protein compared to that of other strains
[30]. However, now we show that there are additional
unique features within the BH1- and BH3-like regions
in M, F and L proteins of strain AF2240, and that
AF2240-M interacts with human Bax protein by its BH3
domain.
Materials and methods
Cell culture
Human cervical cancer cell line, HeLa, was purchased
from American Type Culture Collection (ATCC) and
cultured in Dulbecco’s modified Eagle’sm e d i u m
(DMEM) supplemented with 10% fetal bovine serum
(FBS), 100 U of penicillin/ml and 100 μg of streptomy-
cin/ml in 5% CO2 at 37°C, and routinely checked for
mycoplasma contamination. The cells were infected
with NDV as previously described [15].
qRT-PCR
Real-Time RT-PCR was performed with a two-step sys-
tem optimized for use with Rotor-Gene 6000 Real-Time
PCR machine (Corbett, Australia). Briefly, at different
time points post-infection, HeLa cells were harvested
and total cellular RNA was isolated using RNeasy Mini
kit (Qiagen, USA). cDNA was prepared with a Quanti-
Tect
® RT system (Qiagen, USA) according to manufac-
turer’s instructions. Next, normalized cDNAs were used
in a Hotstart qPCR with Rotor-Gene SYBR green kit
(Qiagen, USA) together with Bax and Bcl-2 QuantiTect
primer sets (Qiagen, USA). The cycling conditions
started with initial 5 min at 95°C followed by 35-40
two-step cycles of 5 sec at 95°C and 10 sec at 60°C. A
melting curve analysis was performed in the end of the
reaction to verify the specificity and identity of the PCR
products. Finally, the ΔΔCt [= (Ct of target gene in sam-
ple - Ct of housekeeping gene in sample) - (Ct of target
gene in control - Ct of housekeeping gene in control)]
and expression (2
-ΔΔCt) values were calculated.
Protein sequence analysis
All protein sequence alignments were performed with
SIM+LALNVIEW at ExPASy proteomics server http://
192.33.215.47/tools/sim-prot.html. Protein BLAST
(BL2SEQ) was used to identify sequence similarities
between NDV viral proteins and human cellular pro-
teins. Prediction of transmembrane helix and interven-
ing loop region was done by TMHMM software, and
prediction of secondary structures was done by PELE
software, both of which are located at San Diego super-
computer center server http://workbench.sdsc.edu/.
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Total RNA was extracted with QIAamp Viral RNA Mini
Kit (Qiagen, USA) from pure stock of Malaysian strain
of NDV strain AF2240, which was grown in 9-day old
embryonated chicken eggs and purified as previously
described [31]. cDNA was made with RevertAid kit (Fer-
mentas, USA). Specific primers were used for amplifying
the cDNAs to enable tagging and cloning of AF2240-M
and AF2240-F viral genes. The PCR primers used for
subcloning the AF2240-M gene into pFLAG-CMV-5a
vector (Mammalian carboxy-terminal FLAG transient
expression kit, Sigma, USA) were 5’-CTTGGAATTCAC-
CATGGACTCATCCAGGGCAATC-3’ for forward and
5’-CTTGGTCGACTTTTTTGAAAGGGTTGTATT-
TAGC-3’ for reverse. The pFLAG-M-N-terminal mutant
was generated by the same forward primer but with a
different reverse primer, 5’-CTTGGTCGACTTGTGG
GGTGATTTGCTTCTT-3’ to amplify 40 a.a. of the N-
terminal. The AF2240-F gene primers used for PCR
amplification and subcloning into the same vector were
5’-CTTGGAATTCACCATGGGCTCCAAGTCTTC-
TACC-3’ for forward and 5’-CTTGGTCGACTGTT
CTTGTGGTGGCTCTCAT-3’ for reverse. Restriction
endonuclease sites EcoRIa n dSalI were chosen for sub-
cloning the PCR fragments into the MCS site of the
pFLAG vector. The AF2240-M gene PCR primers used
for subcloning into pEGFP.N2 (Clontech, USA) were 5’-
AGCTCAAGATCTACCATGGACTCATCCAGGGCA-
3’ for forward and 5’-GAGGTCAAGCTTGCGAAAGGG
TTGTATTTAGCA-3’ for reverse (restriction endonu-
clease sites BglII and HindIII) having two extra nucleo-
tides (in bold) to clone in the same reading frame of the
EGFP tag. Also, a Kozak’s ACC sequence (in bold) was
included in all forward primers to promote the transla-
tion of the target genes in eukaryotic cells. PCR was car-
ried out with a recombinant pfu DNA polymerase
(Fermentas, USA). All PCR products were gel purified
and were first cloned into pJET vector (CloneJET PCR
cloning kit, Fermentas, USA) to increase PCR product
quantity and enhance the chance of cloning to the main
target vectors. Generation of pGFP-Bax, pGFP-Bad and
pGFP-Bcl-XL has been described previously [32].
pcDNA3-FLAG-BimL was a kind gift from Professor
Roger Davis, MIT Medical School, Boston, MA, USA.
All plasmids were transformed into TOP10 E. coli,
grown in LB broth and extracted with PureLink kit
from Invitrogen.
Generation of AF2240-M-ΔBH3 deletion mutant
The plasmid pFLAG-M-ΔBH3 was produced by deletion
of the BH3-like domain in AF2240-M gene. Briefly, two
primers flanking the region between base pairs 67-111
were designed in a way to not disturb the FLAG-tag read-
ing frame (Forward: 5’-ACCCCACAATACAGGAT
CCAG-3’ and Reverse: 5’-TGCTAATAGGCTGCTG-
GAGGGAAG-3’). PCR was run for 20 cycles with 50 ng of
pFLAG-M as template. Recombinant pfu DNA polymerase
was used to proof-read the entire product. Later, the PCR
product was subjected to digestion with Dpn1 enzyme to
eliminate the methylated template DNA. After gel purifi-
cation, the linear PCR product was ligated with T4 ligase
for 3 h at RT, and then transformed into TOP10 E. coli.
Co-transfection and fluorescent microscopy
For transfection, HeLa cells were cultured in 10 cm in
diameter plates at 2 × 10
5 cells/plate. The next day, at a
confluency of 70-80%, the medium was removed and
cells were washed with PBS. Transfection or co-transfec-
tion of cloned plasmids were done with Lipofectamine
LTX and PLUS reagent (Invitrogen, USA) according to
manufacturer’s instructions. Cells were analyzed between
12 h to 48 h post-transfection by flow cytometery, co-
immunoprecipitation, light and fluorescent microscopy.
Flow cytometry and PI staining
On the day of experiment, cells were detached with
Accutase (PAA, USA) and washed with cold PBS (pH
7.4). Floating cells in medium which had died after
transfection were also collected. The pellets were resus-
pended in ice-cold absolute ethanol to fix cells. Cells
were kept in -20°C freezer until they were pelleted down
at the time of experiment. Three hundred microliters of
Propidium iodide (1 μg/ml) containing 10 μg/ml DNase-
free RNase A in PBS was added to each fixed cell pellet.
The pellets were resuspended and incubated for 10 min
before addition of a same volume of sheath buffer. The
stained cells were then analyzed with BD FACSCanto II
flow cytometer. The data were analysed with BD FACS-
Diva and Cyflogic softwares.
Subcellular fractionation
Subcellular fractionation was performed as previously
described [15]. Briefly, transfected cells were collected at
different time points and resuspended in mitochondrial
buffer (70 mM Tris-HCl, 0.25 M sucrose and 1 mM
EDTA, pH 7.4). An equal volume of ice-cold digitonin
lysis buffer (2 mg/ml, 19.8 mM EDTA, 0.25 M D-man-
nitol and 19.8 mM MOPS, pH 7.4) was added for 90 s.
Samples were then centrifuged twice at 300 g for 5 min
to pellet the nuclei. The supernatant was further centri-
fuged at 17,000 g for 20 min to separate mitochondria
from the cytosol. The supernatant was then subjected to
SDS-PAGE and Western blotting with mouse monoclo-
nal anti-Bax 2D2 antibody (Invitrogen, USA).
Co-immunoprecipitation
In order to study protein-protein interactions, the co-
immunoprecipitation approach was tried. A FLAG kit
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transfected cells were harvested and washed with PBS
t w i c eb e f o r eb e i n gr e s u s p e n d e di n1 0 0μLo f2 %
CHAPS lysis buffer (2% CHAPS, 10 mM HEPES pH
7.4, 150 mM NaCl, and 1 tablet of Roche cOmplete™
protease inhibitor) [33,34]. After quantification with
Bradford method, the normalized cell lysates were
added to 0.5 mL microtubes containing 40 μLo fa n t i -
FLAG M2 affinity gel. For positive control, 200 ng of
FLAG-BAP™ fusion protein was used. The microtubes
were rotated end-to-end at 4°C overnight. After incu-
bation, the microtubes were centrifuged at 8000 g for
30 sec. The supernatants were removed and the resins
were washed twice with 0.5% CHAPS buffer. The
cleaned resins were then resuspended in 30 μLo f
SDS-PAGE sample buffer and boiled for 10 min. The
microtubes were then centrifuged at maximum speed
for 5 min and the supernatants were used in SDS-
PAGE and Western blotting.
SDS-PAGE and Western blotting
Proteins in the SDS-polyacrylamide gel were electro-
transferred onto Immobilon-P membrane (Millipore
Corp., USA) and after transferring, the membrane was
blocked with a casein buffer (Pierce, USA). The mem-
brane was incubated either with a monoclonal anti-
FLAG clone M2 raised in mouse (Sigma, USA), or poly-
clonal anti-GFP ab290 raised in rabbit (Abcam, USA) at a
dilution of 1:1000 overnight at 4°C. The blot was then
respectively incubated with an AP-conjugated goat anti-
mouse (Bethyl, USA), or AP-conjugated goat anti-rabbit
(Sigma, USA) at a dilution of 1:1000 for 1 h at room tem-
perature. NBT/BCIP alkaline phosphatase buffer (100
mM Tris-HCl pH 9.5, 100 mM NaCl, 10 mM MgCl2,
containing 3 mg/ml NBT and 1.5 mg/ml BCIP) was used
to develop the blotted membrane (Fermentas, USA).
Statistical analyses
All statistical analyses were performed by Microsoft
Excel. All error bars indicate the standard error of the
mean (SEM). p-values less than 0.05 (*), 0.01 (**) and
0.001 (***) reject the null hypothesis and are referred as
statistically significant.
Results
Infection of HeLa cells with NDV did not alter Bax and
Bcl-2 mRNA levels
HeLa cells were infected with NDV and their RNA was
extracted at different time points post-infection. A rela-
tive comparison of the expression of endogenous Bax
and Bcl-2 before and after NDV infection was studied.
Real-Time PCR with the generated cDNA was carried
out and ΔCt, ΔΔCt and expression (2
-ΔΔCt) values were
calculated according to the Cts of samples and controls
(Figure 1). The values were compared to that of the
housekeeping gene 18S rRNA. Surprisingly, the mRNA
levels of Bax and Bcl-2 before and after NDV infection
did not alter much as no notable increase or decrease
was observed in the Ct values during multiple trials.
Thus, the ratio between Bax and Bcl-2 did not show a
statistically significant alteration following NDV infec-
tion (Figure 1D). At 24 h post-infection many cells died
and detached. These cells were collected separately from
adherent infected cells. For easier presentation, the
uninfected cells, adherent infected cells and floating
infected cells were marked as U, A and F, respectively.
Multiple BH domain-like regions in NDV viral proteins
By BLASTing NDV viral protein sequences in the
BL2SEQ online software at NCBI website, we found
many similar regions between these six proteins (M, L, F,
HN, NP, P) and human cellular proteins (Table 1). Sur-
prisingly, AF2240-M protein scored the highest in terms
of sequence homology to some mammalian proteins such
as RAS p21 activator, B-cell transcription factor 4, and
spectrin beta chain, compared to other viral proteins.
AF2240-L and AF2240-F came in second and third
respectively in the number of matching homologous
sequences. On the other hand, AF2240-HN, AF2240-NP
and AF2240-P did not show much similarity with mam-
malian proteins. Importantly, we found many similarities
between NDV protein sequences and Bcl-2 family mem-
bers, especially for AF2240-L (Table 1). To narrow down
our alignment studies, we compared Bcl-2 homology
domains (BH1, BH2, BH3 and BH4) of many Bcl-2 family
members with sequences from NDV viral proteins by
SIM+LALNVIEW online software at ExPASy website and
identified multiple BH domain-like regions in NDV viral
proteins.
A highly similar BH1-like region was identified in
AF2240-M matrix protein, with four out of eight residues
being identical to those of Bax (Figure 2A). On the other
hand, AF2240-F glycoprotein showed 55% BH1 similarity
with Mcl-1 by having five out of nine residues identical.
Some known conserved residues of BH1 such as aspara-
gine, glycine, valine, and leucine are present in both
AF2240-M and AF2240-F. BH1-like regions are also pre-
sent in AF2240-HN and AF2240-L proteins, but with far
lower scores, with at most four out of nine matching resi-
dues. Thus, they were not further considered due to the
lack of conserved residues. Moreover, we found similar
BH3-like regions in AF2240-L, AF2240-F, and AF2240-M
proteins (Figure 2C). Within this domain, the amino
acids leucine, glycine, and aspartic acid are highly con-
served among various members of the Bcl-2 family and
surprisingly, they are also present in all BH3-like regions
in AF2240-L, AF2240-F and AF2240-M proteins. Our
alignment studies did not reveal any considerable BH2-
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closest sequences are shown in Figure 2B for BH2, and
Figure 2D for BH4, but most conserved residues are
missing.
Subsequently, the BH3-like regions of AF2240 proteins
were aligned with each other to investigate their similar-
ity (Figure 2E). The AF2240-HN glycoprotein, which
showed low similarity to those of Bcl-2 family, surpris-
ingly, had up to six matching residues with AF2240-F
glycoprotein. Although this region is not entirely consid-
ered a BH3-like region, AF2240-HN only lacked one
conserved residue, glycine.
AF2240 shows unique features compared to other strains
All BH3-like sequences of AF2240 were compared to five
other known NDV strains (Figure 3). The residues threo-
nine 38 and glycine 2130, in the BH3-like domain of
AF2240-M and AF2240-L respectively, are unique to the
strain AF2240. Other strains show some shared residues
which are not present in AF2240-L at all. AF2240-F does
not show any uniqueness and most residues are similar to
the other five strains. Only strain La Sota shows a different
methionine residue in the BH3-like region of its F protein.
Both BH1- and BH3-like regions of AF2240-M matrix
protein are located within the N-terminal segment of
the protein (a.a. 99-107 and 27-32, respectively; Figure
4A). In addition, by using TMHMM software, we
showed that the BH3-like region in M protein is located
in the only area that exhibits a minor transmembrane
binding ability in AF2240-M (data not shown). Later we
generated the mutant AF2240-M-ΔBH3 that lacked the
entire BH3-like region between amino acids 23-37 (Fig-
ure 4B), in order to study the effect on cell death and
further analyze the region.
The BH3-like region on AF2240-F protein is located
within F glycoprotein F2 sequence between a.a. 88 to
Figure 1 Real-Time PCR results showing expression of Bax and Bcl-2 mRNAs in HeLa cells following infection with NDV. A. ΔCt of Bax
mRNA. B. ΔCt of Bcl-2 mRNA. C. Bax and Bcl-2 mRNA expression levels. D. Ratio of Bax to Bcl-2 Ct values. Note: All values were against
housekeeping gene 18s rRNA Ct values. No statistically significant difference versus uninfected control cells was observed. Error bars indicate
standard error of the mean from three independent measurements. U: uninfected cells. A: adherent infected cells. F: floating infected cells.
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116-117. BH1-like region of AF2240-F is located in the
C-terminal end between a.a. 411-419, located on F1
before the transmembrane domain at a.a. 501-527 [11].
This observation was further confirmed by TMHMM
prediction software (data not shown). Both Bcl-2 homol-
ogy domain-like regions on AF2240-F are not within
any of the hapted repeats or glycosylation sites.
Compared to members of the Bcl-2 family, the Bax
protein has the highest identity-hits with AF2240-M.
Subsequently, we also found out that the Bax protein has
the highest sequence homology with AF2240-M protein
compared to other tested NDV strains. We also found a
homologous sequence WDSLLSY (Table 1), with 85.7%
identity to the a-8 helix sequence of Bax protein. This
sequence is a part of the BH2 domain of Bax [35] and
surprisingly, no other Bcl-2 family member shows any
higher homology rate with Bax, than AF2240-M does.
The PELE software also showed that BH3-like regions
of AF2240-L, AF2240-F and AF2240-M were all in ran-
dom-coil regions and the BH3-like region of AF2240-F
is right after a Beta-strand, but none of them are in heli-
cal areas, unlike those of many Bcl-2 family members.
AF2240-M and AF2240-F transfections promote apoptosis
To assess the effect of M and F proteins in cell death
regulation, AF2240-M and AF2240-F cDNAs were
cloned into pFLAG-CMV-5a vector and transfected into
HeLa cells. Cells viability was analysed by flow cyto-
metry and fluorescence microscopy. We found that
AF2240-M transfection caused rounding up of cells and
membrane blebbing as early as 12 h post-transfection.
Table 1 Homologous regions between NDV viral proteins and human cellular proteins.
Names Sequences Identity % Score (Bits) Gap %
AF2240-M
B-cell transcription factor 4 leukemia
27 LQDTGDGKKQI 38 LQDTGDILQQI
****** **
72.7 36.0 0.0
AF2240-M
Glucagon-like 1 receptor
297 QWDSLLSYSKCLS
213 QWDGLLSYQDSLS
*** **** **
69.0 27.8 0.0
AF2240-M
Cholecystokinin B receptor
128 VFSVVQA–PRVLQ
191 VYTVVQPVGPRVLQ
* *** *****
64.0 26.9 14.0
AF2240-M
Fibrous sheath-interacting 2
150 SVNAVNHVK
1506 SVNGGNHIK
*** ** *
66.0 20.2 0.0
AF2240-M
Spectrin beta chain, brain 4
46 LDSWTDS
2484 LDSWTDS
*******
100.0 26.5 0.0
AF2240-M
Cytochrome Oxidase
182 WDSLASFRKSLSP
298 WDSLLSYSKCLSP
**** * * ***
69.2 49.0 0.0
AF2240-M
RAS p21 protein activator
4 VLQDTGDGK
449 VLNDTVDGK
** ** ***
77.0 21.0 0.0
AF2240-M
Bid
80 DNPGHEL 95 DALGHEL
* ****
71.4 24.0 0.0
AF2240-M
Bax
298 WDSLLSY
158 WDGLLSY
** ****
85.7 46.0 0.0
AF2240-L
Bcl-2
1540 DFIEMSAKL
110 DFAEMSSQL
** *** *
66.7 31.0 0.0
AF2240-L
Bid
19 NTSRSEE
147 NVSRSEE
* *****
85.7 29.0 0.0
AF2240-L
Bid
86 LRTYVR 2145 LRTYLR
**** *
83.3 27.0 0.0
AF2240-L
Bad
451 EFEPCIEYD
6 EFEPSEQED
**** *
55.6 25.0 0.0
AF2240-F
F-box protein FBW7
21 LILSCICL
8 LILSCICL
********
100.0 29.9 0.0
AF2240-M showed most matching sequences both to cellular proteins and also Bcl-2 family members compared to other viral proteins and strains.
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sis by flow cytometer at 24 h and 48 h post-transfection
(Figure 5A).
To determine the role of the BH3 domain in NDV
viral protein-induced cell death, we truncated the BH3
domain of M and transfected the resulting mutant con-
struct into HeLa cells. As shown in Figure 5A, trunca-
tion of the BH3 domain resulted in a nearly five-fold
decrease in cell death compared to the wild-type
AF2240-M (from 21.49% down to 4.32%). In addition,
we showed that transfection of the plasmid containing
the N-terminal segment of AF2240-M (40 a.a.) also led
to apoptosis, and the rate was almost comparable to the
full-length AF2240-M (21.21%). pFLAG-F showed 12%
less cell death compared to pFLAG-M and this was
further evaluated by histogram analyses shown in Figure
5 B .W eo b s e r v e das h i f tf o rt h eG 0 / G 1p h a s ep e a ki n
the cells transfected with pFLAG-M and pFLAG-F com-
pared to untransfected cells, although the reading
threshold was kept constant for each sample (10,000
events/run).
In addition to PI staining and flow cytometry analysis,
we examined the nuclear morphology of transfected
cells. AF2240-M cDNA was subcloned into the pEGFP.
N2 vector. The resulting pEGFP-M construct or pEGFP.
N2 control vector was transfected into HeLa cells and
stained with DAPI (Figure 6). Transfection with pEGFP-
M led to cell death as evidenced by the presence of
numerous condensed and fragmented nuclei. On the
other hand, in the pEGFP.N2 vector control transfected
cells, the nuclei remained mostly intact.
Moreover, in order to study the localization of Bax
following transfection with pEGFP-M subcellular fractio-
nation was carried out (Figure 7). Cytosolic and heavy
membrane fractions containing mitochondria were sub-
jected to Western blotting analysis with the anti-Bax
2D2 antibody. Bax was primarily localized to the cytoso-
lic fraction before transfection. However, the Bax level
was decreased in the cytosolic fraction following trans-
fection with pEGFP-M. In contrast, the Bax level was
Figure 2 A comparison between Bcl-2 homology domains of
Bcl-2 family members and sequences from NDV strain AF2240
viral proteins. Only identical residues between AF2240 proteins
and Bcl-2 family members are highlighted. A. BH1 domain-like
regions. Note that five out of nine residues of AF2240-F and Mcl-1
in this region are identical. Most conserved residues asparagine,
glycine and valine are highlighted in green. B. BH2 domain-like
regions. A few conserved amino acid residues observed. C. BH3
domain-like regions. Most conserved amino acid residues leucine,
glycine and aspartic acid are highlighted in green. D. BH4 domain-
like regions. Only AF2240-F shows four identical residues to a small
segment of the BH4 domains. E. A comparison of BH3 domain-like
regions between individual proteins of NDV strain AF2240 virus.
Note that this domain is present in four different proteins.
Conserved amino acid residues leucine, glycine and aspartic acid are
present in three out of the four viral proteins (highlighted in green).
AF2240-F and AF2240-HN share many similar residues but the
conserved glycine residue is missing in AF2240-HN.
Figure 4 Schematic diagrams showing the locations of various
BH domain-like regions in different NDV viral proteins. A.
Location of BH1 and BH3 domain-like regions in AF2240-M protein.
Both regions are located near the N-terminus. B. AF2240-M-ΔBH3
lacking a.a. 23-37. C. BH1 and BH3 domain-like regions in AF2240-F
glycoprotein. The area shaded green represents the transmembrane
segment. D. BH3 domain-like region in AF2240-L protein.
Figure 3 An extended comparison of the BH3 domain-like
regions between M, F, and L proteins of various strains of
NDV. Note the unique residue threonine 38 for AF2240-M. Also
note one unique glycine 2130 residue for AF2240 L protein and
some sequence variations between different L proteins.
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Page 7 of 13increased in the heavy membrane fraction of transfected
cells, especially that obtained from the floating cells.
AF2240-M binds to human Bax
HeLa cells were co-transfected with pGFP-Bax, pGFP-
Bad or pGFP-Bcl-XL and pFLAG-M. At different time
points post-transfection, cells were lysed in 2% CHAPS
buffer as described above. Co-IP was carried out by incu-
bation of the cell lysate with anti-FLAG M2-coated pro-
tein G agarose beads. Later, the samples were run on
SDS-PAGE and subjected to two separate immunoblot-
tings with anti-FLAG M2 and anti-GFP primary antibo-
dies (Figure 8). Interestingly, GFP-Bax band was detected
in anti-GFP treated blotting membranes, revealing that
FLAG-tagged AF2240-M directly interacted with
GFP-Bax. In addition, anti-FLAG M2 was able to label
FLAG-tagged AF2240-M on the membrane, confirming
successful purification of the protein by the resin. The
GFP-Bad and GFP-Bcl-XL did not show such interaction
with AF2240-M.
In addition, it was shown that the rate of cell death
caused by pFLAG-F was decreased dramatically (five-
fold) when it was co-transfected with equal amount of
pGFP-Bcl-XL (Figure 9A). However, the co-IP experi-
ments showed no interaction between GFP-Bax, GFP-
Bad or GFP-Bcl-XL and FLAG-tagged AF2240-F. More-
over, in a parallel experiment, the cells were co-trans-
fected with pcDNA3-FLAG-BimL and pEGFP-M, but no
interaction was observed either (data not shown).
AF2240-M interacts by its BH3 domain
In order to investigate if the BH3 domain in AF2240-M
is responsible for binding to Bax, the truncated pFLAG-
M-ΔBH3 was co-transfected with pGFP-Bax. After co-
IP, although FLAG-tagged AF2240-M-ΔBH3 was pre-
sent on the membrane blotted with anti-FLAG M2, no
GFP-Bax was detected on the membranes blotted with
anti-GFP (Figure 10). This showed that FLAG-tagged
AF2240-M-ΔBH3 is not able to bind to GFP-Bax.
Discussion
Our previous results did not show any significant
changes in the total levels of Bax and Bcl-2 proteins fol-
lowing infection of HeLa cells with NDV [15]. In agree-
ment with that, here we have shown that after infection
with NDV, there was very little alteration on the mRNA
levels of Bax and Bcl-2 from those levels (Figure 1).
However, this event could also be strain and/or cell
line-dependent; as shown previously [36], the Bax to
Bcl-2 ratio in Vero cells following NDV infection
changes. It has been observed that after infection of
these cells with NDV, the Bax expression increased
whereas Bcl-2 expression decreased. Therefore, it could
be concluded that NDV-induced apoptosis in these two
cell lines could follow different mechanisms.
Previously, we have shown that AF2240 causes cell
death in HeLa cells within 24 h [15]. This event is asso-
ciated with Bax conformational change and transloca-
tion from the cytoplasm to mitochondria. Subsequently
cytochrome c is released from mitochondria and contri-
butes to cell death via the intrinsic pathway of apoptosis.
In the current study, we further investigated the reason
behind pro-apoptotic ability of NDV by demonstrating
that AF2240-M, AF2240-F and AF2240-L proteins con-
tain BH domain-like regions (Figure 2). By cloning the
AF2240-F and AF2240-M genes (that both contain
BH1- and BH3-like domains) into expression vectors
and transfecting them into HeLa cells, it was shown that
the expressed proteins displayed pro-apoptotic effect
(Figure 5). Later, we showed that mutant AF2240-M-
ΔBH3 had nearly five-fold decrease in cell death rate
compared to the wild-type, while AF2240-M-N-terminal
had the same rate of cell death as to that of the full-
length AF2240-M (Figure 5A).
Figure 5 Quantification of dead HeLa cells following
transfection with various plasmid constructs. A. Percentage of
dead cells only, by flow cytometry and PI staining as a result of
transfection with various constructs. I. pFLAG-M-N-terminal. II.
pFLAG-M-ΔBH3. III. pFLAG-M. IV. pFLAG-F. V. UV-irradiated cells. B.A
histogram analysis of flow cytometry data. The number of dead
cells caused by pFLAG-M transfection was always slightly higher
than those from pFLAG-F transfection. Note the G0/G1 region shift
in cells transfected with pFLAG-M and pFLAG-F.
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regions are responsible for the apoptotic effect of NDV
viral proteins and that they m i g h ti n t e r a c tw i t hB c l - 2
family members. To further investigate, several plasmid
constructs were co-transfected with another into HeLa
cells. Based on co-IP, it was found that the FLAG-tagged
AF2240-M indeed directly bound to the GFP-Bax protein
(Figure 8). All other tested proteins of the Bcl-2 family
failed to interact with either AF2240-M or AF2240-F.
Furthermore, FLAG-tagged AF2240-M-ΔBH3 failed to
interact with GFP-Bax proving that the binding occured
via the BH3 domain of AF2240-M (Figure 10). It was
Figure 6 Transient transfection of HeLa cells with pEGFP-M leads to apoptosis. A. HeLa cells were transfected with either pEGFP or pEGFP-
M construct. At 20 h post-transfection, cells were stained with DAPI and visualized by fluorescence microscopy. Arrow indicates a dead EGFP-M-
positive cells. Arrow-head indicates a dead cell that may have lost its fluorescence due to possible degradation of EGFP-M protein. B. Percentage
of condensed nuclei as compared to control. C. Percentage of EGFP-positive cells. Each data point represents three independent measurements,
and the error bars indicate the standard error of the mean.
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Page 9 of 13concluded that the AF2240-M can also directly bind to
human Bax following NDV infection as long as the plas-
mid constructs expressed proteins that resembled their
natural forms.
Together with our previous results, it could be con-
cluded that binding of the AF2240-M to the endogenous
Bax results in activation of Bax and consequently contri-
butes to its translocation to the outer membrane of
mitochondria (Figure 7), facilitating the release of mito-
chondrial factors such as cytochrome c. It should be
reminded that each NDV virus particle contains a large
number of M protein molecules in the inner side of its
membrane. After NDV entry, all viral proteins are
released inside the host cell, and therefore each M pro-
tein molecule could potentially act as a killer agent to
promote apoptosis. On the other hand, it has been
reported that inactive NDV virus (either chemically
fixed or UV-irradiated) can also exhibit pro-apoptotic
ability [37,38]. Moreover, it has been shown that the
substitutions of both HN and F proteins of mesogenic
strains with velogenic strains did not alter nor increase
the virulence of the virus [39], suggesting other factors
are involved. These findings further supported our
hypothesis that the M protein is a major candidate for
the behavior of NDV.
As shown in Figure 5A, transfection of cells with
pFLAG-F led to cell death, albeit somewhat lower com-
pared to pFLAG-M. Surprisingly, co-transfection of
pFLAG-F and the same amount of pGFP-Bcl-XL led to
a dramatic five-fold drop of death rate (Figure 9A). This
suggests a possible intracellular inhibition of AF2240-F
by Bcl-XL. However, no interaction between FLAG-
tagged AF2240-F and GFP-Bcl-XL was observed. Possibly,
Figure 9 Flow cytometry data after co-transfection of pFLAG-M
or pFLAG-F with pGFP-Bcl-XL. A. pGFP-Bcl-XL reduces the cell
death caused by pFLAG-F by nearly five-fold. B. pGFP-Bcl-XL’s effect
on the rate of cell death caused by pFLAG-M was less significant.
Data are obtained at different time points 24 h, 36 h and 48 h. Each
data point represents three independent measurements, and the
error bars indicate the standard error of the mean. *, p < 0.05 and
**, p < 0.01 were referred to as statistically significant differences.
Figure 8 AF2240-M interacts with Bax. HeLa cells were co-
transfected with pGFP-Bad, pGFP-Bax, pGFP-Bcl-XL or pEGFP.N2 and
pFLAG-M, followed by lysis with 2% CHAPS buffer. Cell lysates were
co-IPed with anti-FLAG M2-coated beads and Western blotted with
either anti-FLAG M2 itself or anti-GFP. FLAG-BAP was used as
control to evaluate successful IP. Total cell lysates were also directly
Western blotted with either of the two antibodies. The double band
at 38 kDa is non-specific. The amounts of total cell lysates loaded
were verified by the actin.
Figure 7 Subcellular localization of Bax in pEGFP-M-transfected
HeLa cells. At 20 h post-transfection the protein samples were
analyzed by Western blotting analysis with the anti-Bax 2D2
antibody. Transfected adherent cells were collected separately from
transfected floating cells (c = cytosolic fraction, m = heavy
membrane fraction, u = untransfected cells, a = transfected
adherent cells, f = transfected floating cells). Bax translocated to the
heavy membrane fraction after transfection with pEGFP-M,
especially in transfected floating cells.
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the action of AF2240-F. In contrast, the reduction of
apoptosis in pGFP-Bcl-XL and pFLAG-M co-transfected
cells was not as significant as pGFP-Bcl-XL and pFLAG-
F co-transfected cells (Figure 9B). Perhaps, AF2240-F and
AF2240-M follow different pathways of apoptosis and/or
GFP-Bcl-XL is not able to sufficiently prevent AF2240-M.
BH3-like region of AF2240-M is located within the
N-terminal segment of the protein (a.a. 27-32). On the
other hand and as stated before, the NDV M protein is
believed to play an important role in the assembly of
the virus by interacting with the nucleocapsid, the lipid
bilayer and also the regions of the surface glycoproteins
that are exposed on the inner surface of the membrane,
but the domains on the M protein that are involved in
binding with the three macromolecules have yet to be
delineated [7]. Surprisingly, by using TMHMM software,
we revealed that BH3-like region in AF2240-M protein
is located in the only area that exhibits a minor trans-
membrane binding ability. Therefore, since many Bcl-2
family members interact with each other via their BH3
domain, further investigation is needed to show whether
NDV M protein interacts with other NDV viral proteins
via this domain.
It should be highlighted that although AF2240-L
showed a higher sequence similarity to the BH3 domain
compared to the rest of the viral proteins (Figure 2C),
there is limitation for cloning and transfection studies
because of the length of its gene (6615 bp).
On the other hand, a number of viral proteins have
been identified that share homology with mammalian
proteins and display either an anti- or pro-apoptotic
effect upon introduction into host cells. We have tabu-
lated some of these viral proteins that share a partial
sequence similarity with Bcl-2 family members in
Table 2. Many of these proteins contain Bcl-2 homology
domains and interact with one or more Bcl-2 family
members. For example, gamma-herpesviruses and few
other herpesviruses encode at least one homolog of Bcl-
2 [40]. African swine fever virus and Adenovirus encode
at least two proteins with BH3 domains that mainly
interact with pro-apoptotic members of Bcl-2 family
[23,27,28,41]. However, most of these viral proteins
show anti-apoptotic effect, and only few of them such as
HCV core protein and HBV HBSP demonstrate pro-
Figure 10 AF2240-M-ΔBH3, unlike AF2240-M, does not interact
with Bax. HeLa cells were co-transfected with pFLAG-M or pFLAG-
M-ΔBH3 and pGFP-Bax, followed by lysis with 2% CHAPS buffer. Cell
lysates were co-IPed with anti-FLAG M2-coated beads and then
Western blotted with either anti-FLAG M2 itself or anti-GFP. FLAG-
BAP was used as control to evaluate successful IP. Total cell lysates
were also directly Western blotted with either of the two
antibodies.
Table 2 Viral proteins that resemble Bcl-2 family members by having one or more BH-like domains
Name Viral
Protein
Function Interacts With Does Not Interact
With
Annotation Reference
Vaccinia Virus FL1 Anti-apoptotic Bax, Bak, Bim - BH3 Domain [29,45]
HCV Core
protein
Pro-apoptotic Mcl-1 Bcl-XL, Bcl-w BH3 Domain [46]
Epstein-Barr Virus BHRF1 Anti-apoptotic Bax, Bak, Bim - BH3 Binding Groove [21,22,47]
Gamma-Herpes Virus 68 M11, vBcl-2 Anti-apoptotic Bim - - [40,48]
Myxoma Virus M11L Anti-apoptotic Bak - BH3 Domain [49]
African Swine Virus A179L, 5-HL Anti-apoptotic Bid, Bax, Bak, Noxa - BH1 Domain [23,41]
Kaposi Sarcoma-Associated
Virus
ORF K12 Anti-apoptotic - Bak, Bax Human Herpesvirus-8. 9
Homologs
[24,25,50]
HBV HBSP Pro-apoptotic - - BH3 Domain [51]
Herpesvirus Saimiri ORF16 Anti-apoptotic Bax, Bak - Conserved BH1, BH2. No BH3 [26,52]
Orf Virus ORFV125 Anti-apoptotic Bik, Puma, Noxa,
Bim
Inactive form of Bax BH3 Domain [53]
Adenovirus E1B-19K Anti-apoptotic, Bax Bcl-2 BH3 Domain [28]
So far only few viral proteins discovered show pro-apoptotic characteristics compared to the rest with anti-apoptotic effects.
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Page 11 of 13apoptotic effect. Here, we added NDV and its viral pro-
teins to this group as not only they contain BH1- and
BH3-like domains and display a pro-apoptotic property,
but also AF2240-M interacts with Bax via its BH3
domain. Similar regions between Bcl-2 family and NDV
proteins could have evolved during early evolution.
The BH3 domain is mainly considered as a pro-apop-
totic domain of the Bcl-2 family of proteins [42].
Although the BH1 domain is generally a pro-survival
domain, it is present in some of the pro-apoptotic mem-
bers such as Bak and Bax. In this study, we show that
although AF2240-M and AF2240-F proteins both con-
tain BH1-like regions, they both display a pro-apoptotic
function (Figure 5). However, BH1-like domain of
AF2240-M was not found to be responsible for its inter-
action with Bax.
Not much is known about the mechanisms underly-
ing the velogenicity of different strains of NDV, but
there is now evidence that the cleavability of F0 is a
major determinant for virulence of NDV virus [43,44].
Therefore, some might argue that a direct transfection
of a plasmid containing full-length F gene would not
fully demonstrate its pro-apoptotic ability as the
expressed product has not undergone post-transla-
tional modification, and therefore it is not in its nat-
ural wild-type form. However, we noticed that the
BH1- and BH3-homologous regions of AF2240-F are
not localised within any of the previously characterised
regions (i.e. HR regions, cleavage site, glycosylation
regions, or transmembrane segment). Thus, AF2240-F
could still exert its apoptotic effect whether it is in its
full-length or cleaved form. On the other hand, unlike
F and HN glycoproteins of NDV, the M protein does
not undergo cleavage and glycosylation. There has
been no report showing that M core protein has a
major post-translational cleavage similar to that of
NDV surface proteins. Therefore, transfection of a full-
length M gene and elicitation of its pro-apoptotic
effect would unlikely to be regulated by post-transla-
tional modification.
AF2240 is a velogenic strain that causes severe intest-
inal lesions and neurological disorders, resulting in high
mortality. Previously it was shown that AF2240-HN pro-
tein of this strain has a different length compared to
those of other strains [30]. Compared to other NDV
strains, the BH3 domain-like sequence in AF2240-M has
threonine 38 residue in place of alanine (Figure 3). In
addition, glycine 2130 is present in the BH3 domain-like
sequence of AF2240-L protein in place of serine. On the
other hand, most L proteins share residues that are not
present in AF2240-L. These differences could potentially
account for the velogenic characteristic of AF2240 com-
pared to milder strains and this is in need of further
investigation.
In conclusion, we have demonstrated that the NDV M
protein is able to interact with human Bax protein by its
BH3 domain. Such interactions could potentially
account for the pro-apoptotic ability of NDV and ulti-
mately lead us to better understanding of the viral
mechanisms.
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